Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2271-2280 of 11918

Edit search filters
  1. MAGNITUDE: A Phase 3 Study Of NTLA-2001 In Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

    Rochester, MN

  2. A Study To Evaluate The Efficacy And Safety Of ALKS 2680 In Adults With Narcolepsy Type 2

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study of Performing the King-Devick Concussion Test in a Right and Left Neck Rotation

  4. Reliability of Various Methods to Test Isometric Strength of Cervical Musculature

  5. A Clinical Study Of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) In People With Breast Cancer (MK-2870-032)

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  6. A Study Of Ultrasound-guided Erector Spinae Plane (ESP) Block Versus Trigger Point Injection (TPI) For Chronic Thoracic Myofascial Pain

    Jacksonville, FL, Rochester, MN

  7. A Study Of Nemolizumab For Chronic Hepatic Pruritus

    Jacksonville, FL

  8. A Study Of Ontunisertib Compared To Placebo In Patients With Fibrostenosing Crohn’s Disease

    Rochester, MN

  9. A Study Of 177Lu-FAP-2286 In Advanced Solid Tumors

    Jacksonville, FL, Rochester, MN

  10. Study To Learn About The Safety Of Fazirsiran And If It Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer